We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$55.7B
AUM Growth
+$1.33B
Cap. Flow
+$2.27B
Cap. Flow %
4.08%
Top 10 Hldgs %
19.71%
Holding
3,688
New
269
Increased
1,855
Reduced
1,236
Closed
227

Sector Composition

Rank Sector Weight
1 Technology 10.05%
2 Financials 9.3%
3 Healthcare 7.74%
4 Industrials 6.94%
5 Communication Services 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STOR
2226
DELISTED
STORE Capital Corporation
STOR
$868K ﹤0.01%
34,987
-29,815
-46% -$724K
WR
2227
DELISTED
Westar Energy Inc
WR
$867K ﹤0.01%
16,477
+172
+1% +$8.69K
FEUZ icon
2228
First Trust Eurozone AlphaDEX
FEUZ
$134M
$865K ﹤0.01%
19,254
+4,756
+33% +$216K
VRE
2229
DELISTED
Veris Residential
VRE
$865K ﹤0.01%
51,766
+584
+1% +$11K
EVA
2230
DELISTED
Enviva Inc.
EVA
$864K ﹤0.01%
31,526
+7,201
+30% +$197K
PCTI
2231
DELISTED
PCTEL, Inc. Common Stock
PCTI
$864K ﹤0.01%
120,312
+51,171
+74% +$368K
INST
2232
DELISTED
Instructure, Inc.
INST
$864K ﹤0.01%
20,488
-393
-2% -$15.5K
AAWW
2233
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$862K ﹤0.01%
14,256
-5,898
-29% -$350K
NGD
2234
DELISTED
New Gold Inc
NGD
$861K ﹤0.01%
333,529
+103,082
+45% +$290K
TCP
2235
DELISTED
TC Pipelines LP
TCP
$860K ﹤0.01%
24,786
+5,614
+29% +$277K
CHE icon
2236
Chemed
CHE
$7.02B
$858K ﹤0.01%
3,143
-22
-0.7% -$5.83K
DHC
2237
Diversified Healthcare Trust
DHC
$2.03B
$858K ﹤0.01%
54,784
-14,202
-21% -$236K
DWLD icon
2238
Davis Select Worldwide ETF
DWLD
$606M
$857K ﹤0.01%
33,005
+15,258
+86% +$414K
PAGP icon
2239
Plains GP Holdings
PAGP
$5.04B
$856K ﹤0.01%
39,347
+2,786
+8% +$61.6K
TTD icon
2240
Trade Desk
TTD
$6.84B
$856K ﹤0.01%
172,430
+44,830
+35% +$230K
AC
2241
DELISTED
Associated Capital Group
AC
$855K ﹤0.01%
22,939
+261
+1% +$9.23K
WNC icon
2242
Wabash National
WNC
$509M
$855K ﹤0.01%
+41,092
New +$927K
EVG
2243
Eaton Vance Short Duration Diversified Income Fund
EVG
$145M
$851K ﹤0.01%
62,380
+44,041
+240% +$608K
UTMD icon
2244
Utah Medical Products
UTMD
$230M
$850K ﹤0.01%
+8,596
New +$767K
MGU
2245
DELISTED
Macquarie Global Infrastructure Total Return Fund, Inc.
MGU
$846K ﹤0.01%
38,114
-295
-0.8% -$6.99K
IPXL
2246
DELISTED
Impax Laboratories, Inc.
IPXL
$846K ﹤0.01%
43,506
+3,582
+9% +$70.3K
FOLD
2247
DELISTED
Amicus Therapeutics
FOLD
$844K ﹤0.01%
56,125
-136,853
-71% -$2.08M
NGL icon
2248
NGL Energy Partners
NGL
$2.13B
$843K ﹤0.01%
76,624
+8,601
+13% +$118K
STRL icon
2249
Sterling Infrastructure
STRL
$16.9B
$842K ﹤0.01%
73,494
-2,052
-3% -$27.1K
BBT
2250
Beacon Financial Corp
BBT
$2.71B
$841K ﹤0.01%
22,153
+272
+1% +$10.3K

Similar funds

Raymond James & Associates's Q1 2018 Portfolio in Review

As of Q1 2018, Raymond James & Associates held 3,688 positions worth $55.7B, up 2.4% from $54.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.27B of net new capital in Q1 2018, opening 269 new positions and adding to 1,855 existing holdings. Its largest new stake was Nutrien: 608,282 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AbbVie, an estimated $68.1M trimmed.

  • Raymond James & Associates's largest Q1 2018 buy was Nutrien: 608,282 shares worth $28.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2018, an estimated $211M increase.
  • Raymond James & Associates's biggest Q1 2018 reduction was AbbVie, cutting an estimated $68.1M.
  • Raymond James & Associates fully exited Regal Entertainment Group in Q1 2018, selling an estimated $48.4M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $55.7B portfolio in Q1 2018.
  • Raymond James & Associates opened 269 new positions and closed 227 in Q1 2018.
  • Raymond James & Associates's portfolio value rose 2.4% quarter-over-quarter to $55.7B.

Based on Raymond James & Associates's 13F filing for Q1 2018, filed 14 May 2018.